Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Beijing Normal University has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are being handled by 3 distinct examiners across 2 distinct art units. This distribution shows that each pending matter has a unique examiner, though some examiners share the same art unit. The use of 2 distinct art units suggests that the university's biotechnology filings are concentrated within a few specialized groups at the USPTO.
YESILDAG, MEHMET is the busiest examiner for the portfolio, currently managing 1 busiest examiner pending action. Since there are 3 pending office actions and 3 distinct examiners, the workload is evenly distributed among the reviewers. The presence of 2 distinct art units for these actions indicates a relatively concentrated review environment within the biotechnology sector. Practitioners should be prepared for unique examiner perspectives while navigating the standards of these two specific art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YESILDAG, MEHMET | 1 | 34.0% | +28.1% |
| KOROTCHKINA, LIOUBOV G | 1 | 29.5% | +67.7% |
| CRAIG, KAILA ANGELIQUE | 1 | 33.8% | +25.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19204733 | HEALTH ASSESSMENT METHOD OF AN AQUATIC ECOSYSTEM BASED ON ECOLOGICAL INTEGRITY AND AN APPLICATION THEREOF | YESILDAG, MEHMET | — |
| 18225937 | INTERPENETRATING NETWORK MICROBIAL HYDROGEL WITH NATURAL POLYSACCHARIDE AND PROTEIN AND PREPARATION METHOD THEREOF | KOROTCHKINA, LIOUBOV G | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19204733 | HEALTH ASSESSMENT METHOD OF AN AQUATIC ECOSYSTEM BASED ON ECOLOGICAL INTEGRITY AND AN APPLICATION THEREOF | YESILDAG, MEHMET | — |
| 18225937 | INTERPENETRATING NETWORK MICROBIAL HYDROGEL WITH NATURAL POLYSACCHARIDE AND PROTEIN AND PREPARATION METHOD THEREOF | KOROTCHKINA, LIOUBOV G | — |
| 17287642 | DIHYDRAZONE COMPOUNDS HAVING HIGH AFFINITY TO A BETA PROTEIN AND TAU PROTEIN, DERIVATIVES THEREOF AND USE THEREOF | CRAIG, KAILA ANGELIQUE | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19204733 | HEALTH ASSESSMENT METHOD OF AN AQUATIC ECOSYSTEM BASED ON ECOLOGICAL INTEGRITY AND AN APPLICATION THEREOF | YESILDAG, MEHMET | — | §101 | Non-Final OA | — | Pending | May 12, 2025 |
| 18225937 | INTERPENETRATING NETWORK MICROBIAL HYDROGEL WITH NATURAL POLYSACCHARIDE AND PROTEIN AND PREPARATION METHOD THEREOF | KOROTCHKINA, LIOUBOV G | 1653 | §103§112 | Final Rejection | — | Pending | Jul 25, 2023 |
| 17287642 | DIHYDRAZONE COMPOUNDS HAVING HIGH AFFINITY TO A BETA PROTEIN AND TAU PROTEIN, DERIVATIVES THEREOF AND USE THEREOF | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Non-Final OA | — | Pending | Apr 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial